Mankind Pharma lists with 20.37% premium on the BSE

9/05/2023 11:33:27 AM | Source: Accord Fintech

Mankind Pharma lists with 20.37% premium on the BSE

News By Tags | #6603 #642 #572

Mankind Pharma has debuted at Rs 1300.00 on the BSE, up by 220 points or 20.37% from its issue price of Rs 1080.

The scrip is currently trading at Rs 1388.30, up by 308.30 points or 28.55% from its issue price. It has touched a high and low of Rs 1395.00 and Rs 1300.00 respectively. So far 7.19 lakh shares were traded on the counter.

The offering, which was open for subscription between April 25, 2023 and April 27, 2023 was subscribed over 15 times. The issue price was fixed at Rs 1080 per share i.e. at upper end of price band of Rs 1026-1080 apiece.

Mankind Pharma develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here

IGI Logo

Mankind Pharma lists with 20.37% premium on the BSE

Top News

Tag News

More News